Valis Bioscience

Pharmaceutical ManufacturingUnited States11-50 Employees

Founded in 2018, Valis is led by scientists with over 20 years of experience working in clinical trials in psychiatry and neurology. We have worked on a range of indications including schizophrenia, depression and anxiety, bipolar disorder, rare and orphan diseases, Parkinson’s disease, Alzheimer’s disease, and the use of psychedelic compounds for PTSD, MDD, AUD, and other conditions. 
Valis was early to recognize the opportunity for the application of 21 CFR Part 11 compliant video recording technology to clinical trials review and clinical therapy monitoring (specifically, in dissociative and psychedelic drug development programs). This has since been deployed in rare and orphan studies where video review is an essential part of the assessment process. 
Valis offers consulting services and clinical trial products and services focused on the integration of scientific expertise, clinical expertise, and healthcare technology.
Services include:
•	 Rater Training and Certification
•	Scientific Consulting
•	Clinical Data Validation
•	Scale Development
•	Statistical Analysis and Validation
•	Scale Licensing and Management
•	Scientific and Psychometric Consulting
•	Protocol Development and Review
•	An exclusive provider of licensed PANSS training
Products include:
•	21 CFR Part 11 Compliant Video Recording System
•	Audio-Video Recording
•	Audio-Only Recording
•	Machine-Learning-Backed Voice-to-Text Transcription
•	Central Review Capabilities
•	QR Code Link to eCOA Technology
•	eClinical Outcomes Assessment (eCOA) Technology
•	Patient and Caregiver Reported Outcomes (PRO) Technology
•	eLearning Management System (LMS) Solutions
•	Application Programming Interface (API) for assessments published 
         by Pearson Clinical Assessments

Sign up for free to view info

Email Format Employee directory